IMMUTEP Ltd
IMMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506184
No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.
Other share classesPRRUF
13F holders, Q1 2024
Institutional positions in IMMUTEP Ltd as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- 0 vs. Q4 2023
- Shares held
- 2.32M
- +276.2K (+13.5%) vs. Q4 2023
- Total value
- $5.40M
- +$501.3K (+10.2%) vs. Q4 2023
- New holders
- 6
- 11 more added
- Sold out
- 6
- 1 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $692.0K |
| Q1 2026 | 26 | $916.3K |
| Q4 2025 | 25 | $5.68M |
| Q3 2025 | 32 | $3.68M |
| Q2 2025 | 24 | $2.75M |
| Q1 2025 | 23 | $2.95M |
| Q4 2024 | 26 | $4.22M |
| Q3 2024 | 23 | $4.26M |
| Q2 2024 | 28 | $4.84M |
| Q1 2024 | 23 | $5.40M |
| Q4 2023 | 23 | $4.90M |
| Q3 2023 | 21 | $3.68M |
| Q2 2023 | 21 | $3.41M |
| Q1 2023 | 19 | $4.95M |
| Q4 2022 | 25 | $7.25M |
| Q3 2022 | 21 | $8.31M |
| Q2 2022 | 22 | $11.2M |
| Q1 2022 | 23 | $14.4M |
| Q4 2021 | 25 | $17.5M |
| Q3 2021 | 28 | $30.9M |
| Q2 2021 | 28 | $32.9M |
| Q1 2021 | 13 | $14.0M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding IMMUTEP Ltd; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 181 | $422 | 0.00% | +181 | New |
| Bank of America Corp | 778 | $1.81K | 0.00% | +776+38,800.0% | Added |
| JPMorgan Chase & Co | 1,753 | $4.08K | 0.00% | +1,753 | New |
| Tower Research Capital LLC (TRC) | 2,689 | $6.26K | 0.00% | +2,589+2,589.0% | Added |
| Group One Trading, L.P. | 2,917 | $6.80K | 0.00% | −735−20.1% | Reduced |
| Wells Fargo & Company | 4,500 | $10.5K | 0.00% | +4,500 | New |
| Citadel Advisors LLC | 12,933 | $30.1K | 0.00% | +12,933 | New |
| Geode Capital Management, LLC | 18,722 | $43.6K | 0.00% | 00.0% | Unchanged |
| Eagle Strategies LLC | 22,800 | $53.1K | 0.01% | +22,800 | New |
| Morgan Stanley | 26,000 | $60.6K | 0.00% | +2,501+10.6% | Added |
| Royal Bank of Canada | 25,995 | $61.0K | 0.00% | +25,929+39,286.4% | Added |
| Rhumbline Advisers | 26,943 | $62.8K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 30,000 | $69.9K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 32,071 | $74.0K | 0.00% | +3,686+13.0% | Added |
| BNP Paribas Arbitrage, SA | 35,300 | $82.2K | 0.00% | +4,700+15.4% | Added |
| Virtu Financial LLC | 45,062 | $105.0K | 0.01% | +32,864+269.4% | Added |
| PFG Investments, LLC | 51,000 | $118.8K | 0.01% | +51,000 | New |
| Dimensional Fund Advisors LP | 70,005 | $163.1K | 0.00% | 00.0% | Unchanged |
| Caption Management, LLC | 73,292 | $170.8K | 0.02% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 172,801 | $402.6K | 0.00% | +73,528+74.1% | Added |
| Millennium Management LLC | 349,461 | $814.2K | 0.00% | +289,035+478.3% | Added |
| Oracle Investment Management Inc | 564,879 | $1.32M | 1.06% | +48,449+9.4% | Added |
| BlackRock Inc. | 749,460 | $1.75M | 0.00% | +103,232+16.0% | Added |
| Meridian Wealth Management, LLC | 0 | $0 | 0.00% | −322,450−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −52,468−100.0% | Sold out |
| GTS Securities LLC | 0 | $0 | 0.00% | −24,596−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −3,800−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −196−100.0% | Sold out |